Irbesartan treatment does not influence plasma levels of the advanced glycation end products N{varepsilon}(1-carboxymethyl)lysine and N{varepsilon}(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial

05 sep 2011

Auteurs: Engelen L, Persson F, Ferreira I, Rossing P Hovind P, Teerlink T, Stehouwer CD, Parving HH, Schalkwijk CG
Edition 2011 Mar 8
Tijdschrift Nephrol Dial Transplant

Principal investigators



back to the list of publications